The size of the dialysis equipment market in the Asia-Pacific region is forecasted to worth USD 5.99 billion by 2026 from USD 3.74 billion in 2021, witnessing a CAGR of 9.9% during the forecast period.
The APAC dialysis equipment market is expected to be majorly driven by the enormously increasing incidence of end-stage renal disease and rising chronic kidney diseases. Also, the government initiatives and support for treating end-stage renal disease and chronic kidney provide exponential growth to the Dialysis Equipment market in the APAC region. Increasing healthcare infrastructure is expected to offer growth opportunities in Asia pacific. There has been a rising demand for peritoneal dialysis in emerging countries such as China and India are most likely to increase the market growth. Furthermore, the growing number of hospitals and the rising number of dialysis centers in the developing countries and combined treatments are expected to increase the regional market growth.
Also, rising technological advancements to enhance medical services and treatments influence the market growth. However, growing awareness about the diseases and therapeutic modalities are expected to drive the market. Rising investment and funding by the government in the region accelerate the market growth. Further, the growing need for the emergence of dialysis and laboratories are further increases the market growth. Needless to say, dialysis has been an expensive process for kidney therapy, which is why the dialysis equipment market is booming to make renal care more accessible. Chronic kidney disease (CKD) will continue to drive demand for dialysis treatments, which will be exacerbated by the aging population and increased life expectancy. Also, Market companies in the region taking advantage of development chances help to push market growth. Growing healthcare insurance countries like India boost market growth.
However, issues such as a lack of understanding about the therapy, a rise in demand for new dialysis instruments, and worries about the risks of dialysis are projected to hamper the market growth. Renal dialysis equipment market development is expected to be hindered by stringent regulations, high prices for sophisticated treatments, and a scarcity of skilled professionals over the projected period.
This research report on the APAC Dialysis Equipment Market has been segmented and sub-segmented into the following categories:
By Type:
By End-User:
By Country:
Regional Analysis:
APAC is the fastest-growing regional market worldwide and is anticipated to register a healthy growth rate owing to the supportive government initiatives, increasing healthcare spending, and advancing technology in the healthcare sector in the region. Pediatric dialysis will provide an attractive potential for manufacturers. Furthermore, increased demand for cost-effective equipment in APAC's low and middle-income nations will create new revenue streams." China and Japan are anticipated to witness rapid growth during the forecast period. In 2019, the dialysis market in Japan generated around USD 6,200.8 million in revenue. The dialysis market in the nation would be driven by improved healthcare infrastructure and supporting government efforts.
Furthermore, market development would be aided by an expanding elderly population and expanding home dialysis and peritoneal dialysis usage. The Indian market is growing significantly due to recent industry developments, including mergers and acquisitions. For instance, Medtronic Inc. of Minnesota, for example, partnered with India's Apollo Hospitals Enterprise Ltd to join the renal dialysis market. Patients in poorer nations are less likely to have access to high-end treatment; thus, they demand alternatives that use less water and infrastructure.
KEY MARKET PLAYERS:
Fresenius Medical, Care AG & Co, Gambro AB, Baxter International Inc, Nipro Inc, ALL-MED Medical GmbH, Asahi Kasei Corporation are a few notable companies in the APAC dialysis equipment market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Hemodialysis Equipment
5.1.2.1 Hemodialysis Machines
5.1.2.2 Dialyzers
5.1.2.3 Blood Access Device Dialysate
5.1.3 Peritoneal Dialysis Equipment
5.1.3.1 Continuous Cycling Peritoneal Dialysis
5.1.3.2 Continuous Ambulatory Peritoneal Dialysis
5.1.3.3 Intermittent Peritoneal Dialysis
5.1.4 Continuous Renal Replacement Therapy Systems
5.1.5 Dialysis Accessories
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 End-User
5.3.1 Introduction
5.3.2 In-Center Dialysis
5.3.3 Homecare Dialysis
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of Asia Pacific
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Gambro AB
8.3 Baxter International Inc.
8.4 Nipro Inc.
8.5 ALLMED Medical GmbH
8.6 Asahi Kasei Corporation
8.7 Celgene Corporation
8.8 Invitrogen
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
